Preventing non bacteremic pneumococcal pneumonia in older adults: Historical background and considerations for choosing between PCV13 and PPV23

Podobne knjige/članki

• 1972. Safety and Immunogenicity of 15-Valent Pneumococcal Conjugate Vaccine (PCV-15) Compared with PCV-13 in Healthy Older Adults Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23)
  od: Buchwald, Ulrike, et al.
  Izdano: (2018)
• 1434. Cost-Effectiveness of Sequencial Vaccination With the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Followed by the 23 Valent Polysaccharide Vaccine (PPV23) in The Netherlands
  od: Rozenbaum, Mark
  Izdano: (2018)
• 1474. Impact of 13-valent Pneumococcal Conjugate Vaccine (PCV13) on Non-bacteremic Pneumococcal Pneumonia (NBPP) among Adults in the United States, 2013-2017
  od: Gierke, Ryan, et al.
  Izdano: (2020)
• Is 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Combined With 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23) Superior to PPSV23 Alone for Reducing Incidence or Severity of Pneumonia in Older Adults? A Clin-IQ
  od: Hayward, Starla, et al.
  Izdano: (2016)
• Epididymitis associated with bacteremic pneumococcal pneumonia
  od: Berlinrut, Ilan, et al.
  Izdano: (2021)